← Leaderboards
Emanuela Gussoni
Boston Children'S Hospital
$10,178,946
Attributed
$10,178,946
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,178,946 · 6
By mechanism
R01$8,832,430 · 4
P50$1,093,089 · 1
P01$253,427 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Michael William Lawlor$1,085,247
- Pankaj B Agrawal$4,271,823
- Ingrid Adele Holm$10,979,890
- Youngsook Lucy Jung$241,380
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMuscleMuscle CellsFetalIn VivoTissuesMononuclearSignal TransductionMyoblastsStem CellsSkeletal Muscle StructureMuscle FibersAdultIn VitroMuscle Satellite CellGenesRepairedProgenitorProteinsDefectDystrophinCell TypeSatellite CellGene Expression
Grant awards (30)
Epigenetic dysregulation of muscle differentiation in Kabuki syndrome$514,132
R01 · FY2025 · AR · contact PI
Epigenetic dysregulation of muscle differentiation in Kabuki syndrome$514,132
R01 · FY2024 · AR · contact PI
Epigenetic dysregulation of muscle differentiation in Kabuki syndrome$530,034
R01 · FY2023 · AR · contact PI
Epigenetic dysregulation of muscle differentiation in Kabuki syndrome$553,354
R01 · FY2022 · AR · contact PI
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation$385,506
R01 · FY2022 · AR · contact PI
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation$377,718
R01 · FY2021 · AR · contact PI
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation$389,400
R01 · FY2019 · AR · contact PI
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation$384,093
R01 · FY2018 · AR · contact PI
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation$384,093
R01 · FY2017 · AR · contact PI
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION$391,500
R01 · FY2015 · AR · contact PI
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION$383,670
R01 · FY2014 · AR · contact PI
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION$371,925
R01 · FY2013 · AR · contact PI
SP cells and downstream progenitors in human and mouse muscle$359,957
R01 · FY2013 · NS · contact PI
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION$391,500
R01 · FY2012 · AR · contact PI
SP cells and downstream progenitors in human and mouse muscle$373,013
R01 · FY2012 · NS · contact PI
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION$390,750
R01 · FY2011 · AR · contact PI
SP cells and downstream progenitors in human and mouse muscle$371,226
R01 · FY2011 · NS · contact PI
Progenitor Cells inHuman Skeletal Muscle$273,486
P50 · FY2011 · NS · contact PI
SP cells and downstream progenitors in human and mouse muscle$371,586
R01 · FY2010 · NS · contact PI
Progenitor Cells inHuman Skeletal Muscle$268,618
P50 · FY2010 · NS · contact PI
SP cells and downstream progenitors in human and mouse muscle$372,240
R01 · FY2009 · NS · contact PI
Progenitor Cells inHuman Skeletal Muscle$274,752
P50 · FY2009 · NS · contact PI
Progenitor Cells inHuman Skeletal Muscle$276,233
P50 · FY2008 · NS · contact PI
Progenitor Cells inHuman Skeletal Muscle$253,427
P01 · FY2007 · NS · contact PI
Delivery of human muscle SP cells to dystrophic muscle$244,263
R01 · FY2007 · NS · contact PI
Delivery of human muscle SP cells to dystrophic muscle$251,558
R01 · FY2006 · NS · contact PI
Delivery of human muscle SP cells to dystrophic muscle$257,497
R01 · FY2005 · NS
Delivery of human muscle SP cells to dystrophic muscle$269,283
R01 · FY2004 · NS
GENE EXPRESSION % THERAPEUTIC APPLICATION OF MUSCLE STEM CELLS$0
P01 · FY2002 · NS
GENE EXPRESSION % THERAPEUTIC APPLICATION OF MUSCLE STEM CELLS$0
P01 · FY2001 · NS